(1-287) Comparing Outcomes and Toxicities with Standard and Reduced Dose Melphalan in Autologous Stem Cell Rescue Patients with Multiple Myeloma

Sunday, December 4, 2022

3:30 PM – 5:00 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Oncology/Hematology

Co-Author(s): Ryan Archer

Primary Author(s)

Katie Rogers, PharmD
Resident
Veterans Affairs Tennessee Valley Healthcare System, Tennessee